trending Market Intelligence /marketintelligence/en/news-insights/trending/1Hp_Vc_K07bV-iGT1hNCmg2 content esgSubNav
In This List

Universal Biosensors acquiring hemostasis reference lab business

Blog

A Cloud Migration Plan for Corporations featuring Snowflake®

Blog

Investor Activism Campaigns Hit Record High in 2022

Blog

Essential IR Insights Newsletter - February 2023

Blog

Insight Weekly: US bank margins rise; smartphone shipments drop; coal miners book strong sales


Universal Biosensors acquiring hemostasis reference lab business

Universal Biosensors Inc. is acquiring Lifelabs LP's hemostasis reference laboratory business to meet increased production demand.

Universal Biosensors manufactures Siemens Healthcare Diagnostics' Xprecia Stride test strips to diagnose potential heart attack-inducing blood clots.

Universal Biosensors did not disclose the terms of the acquisition.